Nucleus accumbens D2- and D1-receptor expressing medium spiny neurons are selectively activated by morphine withdrawal and acute morphine, respectively

Neuropharmacology

Volumn 62, Issue 8, 2012, Pages 2463-2471

  Enoksson, T ^a,b   Bertran Gonzalez, J ^a   Christie, M J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

D1 receptor; D2 receptor; Morphine; Morphine withdrawal; Nucleus accumbens

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DRUG ACTIVITY; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MEDIUM SIZED SPINY NEURON; MORPHINE ADDICTION; MOUSE; NERVE CELL; NERVE CELL STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; WITHDRAWAL SYNDROME;

ANIMALS; CELL LINE; MALE; MICE; MICE, TRANSGENIC; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NEURONS; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84859727772     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.02.020     Document Type: Article

References (57)

1. Ade, K.K., Wan, Y., Chen, M., Gloss, B., Calakos, N., 2011. An improved BAC transgenic fluorescent reporter line for sensitive and specific identification of striatonigral medium spiny neurons. Front. Syst. Neurosci. 5, 32.
2. Alexander, G.E., DeLong, M.R., Strick, P.L., 1986. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9, 357-381. (Pubitemid 16055790)
3. Bagley, E., Hacker, J., Chefer, V., Mallet, C., Peroud, J., McNally, G., Chieng, B., Shippenberg, T., Christie, M., 2011. Drug-induced GABA transporter currents enhance GABA release and produce opioid withdrawal behaviours. Nat. Neurosci. 14, 1548-1554.
4. Berretta, S., Robertson, H.A., Graybiel, A.M., 1992. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68, 767-777.
5. Bertran-Gonzalez, J., Bosch, C., Maroteaux, M., Matamales, M., Hervé, D., Valjent, E., Girault, J.-A., 2008. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J. Neurosci. 28, 5671-5685.
6. Bertran-Gonzalez, J., Håkansson, K., Borgkvist, A., Irinopoulou, T., Brami-Cherrier, K., Usiello, A., Greengard, P., Hervé, D., Girault, J.A., Valjent, E., Fisone, G., 2009. Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology 34 (7), 1710-1720.
7. Bertran-Gonzalez, J., Hervé, D., Girault, J.-A., Valjent, E., 2010. What is the degree of segregation between striatonigral and striatopallidal projections? Front. Neuroanat. 4.
8. Bohn, L.M., Gainetdinov, R.R., Sotnikova, T.D., Medvedev, I.O., Lefkowitz, R.J., Dykstra, L.A., Caron, M.G., 2003. Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J. Neurosci. 23, 10265-10273. (Pubitemid 37444603)
9. Bontempi, B., Sharp, F.R., 1997. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17, 8596-8612. (Pubitemid 27461080)
10. Chang, S.L., Squinto, S.P., Harlan, R.E., 1988. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157, 698-704. (Pubitemid 19021236)
11. Chieng, B., Williams, J.T., 1998. Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J. Neurosci. 18, 7033-7039. (Pubitemid 28388032)
12. Chieng, B., Azriel, Y., Mohammadi, S., Christie, M.J., 2011. Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J. Physiol. 589, 3775-3787.
13. Chieng, B.C., Hallberg, C., Nyberg, F.J., Christie, M.J., 2005. Enhanced c-Fos in periaqueductal grey GABAergic neurons during opioid withdrawal. Neuroreport 16, 1279-1283. (Pubitemid 41225196)
14. Collier, H.O.J., Francis, D.L., Schneider, C., 1972. Modification of morphine withdrawal by drugs interacting with humoral mechanisms: some contradictions and their interpretation. Nature 237, 220-223.
15. Diana, M., Pistis, M., Muntoni, A., Gessa, G., 1995. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharmacol. Exp. Ther. 272, 781-785.
16. Di Chiara, G., North, R.A., 1992. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13, 185-193.
17. Dong, H.W., 2008. The Allen Reference Atlas: A Digital Color Brain Atlas of the C57BL/6J Male Mouse, first ed. Wiley.
18. Garcia, M.M., Brown, H.E., Harlan, R.E., 1995. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res. 692, 23-40.
19. Georges, F., Stinus, L., Le Moine, C., 2000. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur. J. Neurosci. 12, 4475-4486. (Pubitemid 32040927)
20. Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma Jr., F.J., Sibley, D.R., 1990. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432. (Pubitemid 120031867)
21. Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, N.J., Joyner, A., Leblanc, G., Hatten, M.E., Heintz, N., 2003. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425, 917-925. (Pubitemid 37376918)
22. Gracy, K.N., Dankiewicz, L.A., Koob, G.F., 2001. Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24, 152-160.
23. Hacker, J., Pedersen, N.P., Chieng, B.C.H., Keay, K.A., Christie, M.J., 2006. Enhanced Fos expression in glutamic acid decarboxylase immunoreactive neurons of the mouse periaqueductal grey during opioid withdrawal. Neuroscience 137, 1389-1396. (Pubitemid 43133162)
24. Hamlin, A., Buller, K.M., Day, T.A., Osborne, P.B., 2001. Peripheral withdrawal recruits distinct central nuclei in morphine-dependent rats. Neuropharmacology 41, 574-581. (Pubitemid 32924967)
25. Hayward, M.D., Duman, R.S., Nestler, E.J., 1990. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of rat brain. Brain Res. 525, 256-266. (Pubitemid 20257744)
26. Hebb, A.L.O., Zacharko, R.M., Gauthier, M., Trudel, F., Laforest, S., Drolet, G., 2004. Brief exposure to predator odor and resultant anxiety enhances mesocorticolimbic activity and enkephalin expression in CD-1 mice. Eur. J. Neurosci. 20, 2415-2429. (Pubitemid 39472403)
27. Hughes, P., Dragunow, M., 1995. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133-178.
28. Hyman, S.E., Malenka, R.C., Nestler, E.J., 2006. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29, 565-598. (Pubitemid 44476856)
29. Jalabert, M., Bourdy, R., Courtin, J., Veinante, P., Manzoni, O.J., Barrot, M., Georges, F., 2011. Neuronal circuits underlying acute morphine action on dopamine neurons. Proc. Natl. Acad. Sci. U S A 108, 16446-16450.
30. Johnson, S.W., North, R.A., 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488.
31. Kawaguchi, Y., 1997. Neostriatal cell subtypes and their functional roles. Neurosci. Res. 27, 1-8. (Pubitemid 27117091)
32. Koob, G.F., Maldonado, R., Stinus, L., 1992. Neural substrates of opiate withdrawal. Trends Neurosci. 15, 186-191.
33. Koob, G.F., Wall, T.L., Bloom, F.E., 1989. Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacol. (Berl.) 98, 530-534. (Pubitemid 19193903)
34. Kramer, P.F., Christensen, C.H., Hazelwood, L.A., Dobi, A., Bock, R., Sibley, D.R., Mateo, Y., Alvarez, V.A., 2011. Dopamine D2 receptor overexpression alters behavior and physiology in Drd2-EGFP mice. J. Neurosci. 31, 126-132.
35. Liu, J., Nickolenko, J., Sharp, F.R., 1994. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U S A 91, 8537-8541. (Pubitemid 24273699)
36. Madhavan, A., He, L., Stuber, G.D., Bonci, A., Whistler, J.L., 2010. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. J. Neurosci. 30, 3276-3286.
37. Maldonado, R., Stinus, L., Gold, L.H., Koob, G.F., 1992. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261, 669-677.
38. Manzoni, O.J., Williams, J.T., 1999. Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J. Neurosci. 19, 6629-6636. (Pubitemid 29347462)
39. Matamales, M., Bertran-Gonzalez, J., Salomon, L., Degos, B., Deniau, J.-M., Valjent, E., Hervé, D., Girault, J.-A., 2009. Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice. PLoS ONE 4, e4770.
40. Matsui, A., Williams, J.T., 2011. Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J. Neurosci. 31, 17729-17735.
41. Mazei-Robison, M.S., Koo, J.W., Friedman, A.K., Lansink, C.S., Robison, A.J., Vinish, M., Krishnan, V., Kim, S., Siuta, M.A., Galli, A., Niswender, K.D., Appasani, R., Horvath, M.C., Neve, R.L., Worley, P.F., Snyder, S.H., Hurd, Y.L., Cheer, J.F., Han, M.H., Russo, S.J., Nestler, E.J., 2011. Role for mTOR signaling and neuronal activity in morphine-induced adaptations in ventral tegmental area dopamine neurons. Neuron 72, 977-990.
42. Moratalla, R., Xu, M., Tonegawa, S., Graybiel, A.M., 1996. Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc. Natl. Acad. Sci. U S A 93, 14928-14933. (Pubitemid 26419072)
43. Ouimet, C.C., Miller, P.E., Hemmings Jr., H.C., Walaas, S.I., Greengard, P., 1984. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate- regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111-124. (Pubitemid 14198292)
44. Perreault, M.L., Hasbi, A., Alijaniaram, M., Fan, T., Varghese, G., Fletcher, P.J., Seeman, P., O'Dowd, B.F., George, S.R., 2010. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J. Biol. Chem. 285, 36625-36634.
45. Pothos, E., Rada, P., Mark, G.P., Hoebel, B.G., 1991. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 566, 348-350.
46. Rasmussen, K., Brodsky, M., Inturrisi, C.E., 1995. NMDA antagonists and clonidine block c-fos expression during morphine withdrawal. Synapse 20, 68-74.
47. Richfield, E.K., Penney, J.B., Young, A.B., 1989. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. Neuroscience 30, 767-777. (Pubitemid 19197155)
48. Robertson, H.A., Paul, M.L., Moratalla, R., Graybiel, A.M., 1991. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can. J. Neurol. Sci. 18, 380-383.
49. Rossetti, Z.L., Hmaidan, Y., Gessa, G.L., 1992. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmacol. 221, 227-234.
50. Sheng, M., Greenberg, M.E., 1990. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 4, 477-485. (Pubitemid 20160837)
51. Shuen, J.A., Chen, M., Gloss, B., Calakos, N., 2008. Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. J. Neurosci. 28, 2681-2685. (Pubitemid 351398859)
52. Sora, I., Elmer, G., Funada, M., Pieper, J., Li, X.F., Hall, F.S., Uhl, G.R., 2001. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology 25, 41-54. (Pubitemid 32493821)
53. Stinus, L., Le Moal, M., Koob, G.F., 1990. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37, 767-773. (Pubitemid 20282214)
54. Taracha, E., Lehner, M., Wis1owska-Stanek, A., Zienowicz, M., Maciejak, P., Bidziński, A., Skórzewska, A., Turzyńska, D., Płaźnik, A., 2006. Effects of methadone and morphine on c-Fos expression in the rat brain: similarities and differences. Pharmacol. Rep. 58, 120-124.
55. Valjent, E., Bertran-Gonzalez, J., Hervé, D., Fisone, G., Girault, J.-A., 2009. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends Neurosci. 32, 538-547.
56. Williams, J.T., Christie, M.J., Manzoni, O., 2001. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343. (Pubitemid 32096178)
57. Young, S.T., Porrino, L.J., Iadarola, M.J., 1991. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. U S A 88, 1291-1295. (Pubitemid 21916210)